American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 2 , Pages 119-128 , March 2006

Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review

  • Mohammed A. Qadeer, MD

      Affiliations

    • Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, OH, USA
    • ,
  • Natalie Colabianchi, PhD

      Affiliations

    • Department of Epidemiology, Case Western Reserve University, Cleveland, OH, USA
    • ,
  • Marshall Strome, MD

      Affiliations

    • Department of Otolaryngology, Cleveland Clinic Foundation, Cleveland, OH, USA
    • ,
  • Michael F. Vaezi, MD, PhD, MSepi

      Affiliations

    • Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, OH, USA
    • Corresponding Author InformationCorresponding author. 1501 TVC, 1301 22nd Avenue South, Nashville, TN 37232-5280, USA. Tel.: +1 615 322 0128; fax: +1 615 343 8174.

Received 19 November 2004

References 

  1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease: a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;101(53):1–78
  2. Olson NR. Effects of stomach acid on the larynx. Proc Am Laryngol Assoc. 1983;104:108–112
  3. Morrison MD. Is chronic gastroesophageal reflux a causative factor in glottic carcinoma?. Otolaryngol Head Neck Surg. 1988;99:370–373
  4. Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope. 1988;98:1195–1199
  5. Price JC, Jansen CJ, Johns ME. Esophageal reflux and secondary malignant neoplasia at laryngoesophagectomy. Arch Otolaryngol Head Neck Surg. 1990;116:163–164
  6. Frejie JE, Beatty TW, Campbell BH, et al. Carcinoma of the larynx in patients with gastroesophageal reflux. Am J Otolaryngol. 1996;17:386–390
  7. Biacabe B, Gleich LL, Laccourreye O, et al. Silent gastroesophageal reflux disease in patients with pharyngolaryngeal cancer: further results. Head Neck. 1998;510–514
  8. Copper MP, Smit CF, Stanojcic LD, et al. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. Laryngoscope. 2000;110:1007–1011
  9. Lewin JS, Gillenwater AM, Garrett JD, et al. Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx. Cancer. 2003;97:1010–1014
  10. Galli J, Cammarota G, Calo L, et al. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma. Laryngoscope. 2002;112:1861–1865
  11. Mercante G, Bacciu T, Ferri T, et al. Gastroesophageal reflux as a possible co-promoting factor in the development of the squamous cell carcinoma of the oral cavity, of the larynx and of the pharynx. Acta Otorhinolaryngol Belg. 2003;57:113–117
  12. El-Serag HB, Hepworth EJ, Lee P, et al. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001;96:2013–2018
  13. Cann CI, Fried MP, Rothman KJ. Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin North Am. 1985;18:367–388
  14. Landis S, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6–295
  15. Rothman KJ, Cann CI, Flanders W, et al. Epidemiology of laryngeal cancer. Epidemiol Rev. 1980;2:195–209
  16. Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res. 1977;37:4608–4622
  17. Muir C, Weinland L. Upper aerodigestive tract cancers. Cancer. 1995;75:147–153
  18. Spitz MR, Fueger JJ, Goepfert H, et al. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer. 1988;61:203–208
  19. Berrino F, World Health Organization , International Agency for Research on Cancer , et al. Survival of cancer patients in Europe: the EUROCARE-2 study. Lyon: International Agency for Research on Cancer; 1999;[IARC scientific publications; no. 151]
  20. Parker SL, et al. Cancer statistics, 1996. Cancer. 1996;46:819
  21. Wasfie T, Newman R. Laryngeal carcinoma in black patients. Cancer. 1988;61:167
  22. Moore C. Cigarette smoking and cancer of mouth, pharynx and larynx: a continuing study. JAMA. 1987;218:553–558
  23. Zeka A, Gore R, Kriebel D. Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control. 2003;14:897–906
  24. Falk RT, Pickle LW, Brown LM, et al. Effect of smoking and alcohol consumption on laryngeal cancer risk in coastal Texas. Cancer Res. 1989;49:4024–4029
  25. Hedberg K, Vaughn TL, White E, et al. Alcoholism and cancer of larynx: a case-control study in western Washington. Cancer Causes Control. 1994;5:3–8
  26. Wynder EL, Convey LS, Mabuchi K, et al. Environmental factors in cancer of larynx: a second look. Cancer. 1976;38:1591–1601
  27. Franceschi S, Munoz N, Bosch XF, et al. Human papillomavirus and cancers of upper aerodigestive tract: a review of epidemiologic and experimental evidence. Cancer Epidemiol Biomarkers Prev. 1996;5:567–575
  28. Fontham ET. Protective dietary factors and lung cancer. Int J Epidemiol. 1990;19:S32–S42
  29. Brown LM, Mason TJ, Pickle LW, et al. Occupational risk factors for laryngeal cancer on the Texas Gulf Coast. Cancer Res. 1988;48:1960–1964
  30. Flanders WD, Rothman KJ. Occupational risk for laryngeal cancer. Am J Public Health. 1982;72:369–372
  31. Goolden AWG. Radiation cancer: a review with special reference to radiation tumors in the pharynx, larynx and thyroid. Br J Radiol. 1957;130:628–640
  32. Copper MP, Jovanovic A, Nauta JJP, et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolarygol. 1995;121:157–160
  33. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287–1289
  34. Mork J, Glattre E. Squamous cell carcinomas of the head and neck in Norway, 1953–92: an epidemiologic study of a low-risk population. Cancer Causes Control. 1998;9:37–48
  35. Devesa SS, Silverman DT, Young JL, et al. Cancer incidence and mortality trends among whites in the United States, 1947–84. J Natl Cancer Inst. 1987;79:701–770
  36. Centers for Disease Control and Prevention . Tobacco use—United States, 1900–1999. MMWR Morb Mortal Wkly Rep. 1999;48:986–993[erratum in: MMWR Morb Mortal Wkly Rep 48 (1999) 1027]
  37. In:  Ries LAG,  Eisner MP,  Kosary CL, et al. editor. SEER cancer statistics review, 1975–2001. Bethesda (Md): National Cancer Institute; 2004;http://seer.cancer.gov/csr/1975_2001/
  38. Locke GR, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106:642–649
  39. Dennish GW, Castell DO. Inhibitory effect of smoking on the lower esophageal sphincter. N Engl Med J. 1971;284:1136–1137
  40. Smit CF, Copper MP, van Leeuwen JA, et al. Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux. Ann Otol Rhinol Laryngol. 2001;110:190–193
  41. Kadakia SC, Kikendall JW, Maydonovitch C, et al. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol. 1995;90:1785–1790
  42. Kaufman SE, Kaye MD. Induction of gastro-oesophageal reflux by alcohol. Gut. 1978;19:336–338
  43. Vitale GC, Cheadle WG, Patel B, et al. The effect of alcohol on nocturnal gastroesophageal reflux. JAMA. 1987;258:2077–2079
  44. Gabriel CE, Jones DG. The importance of chronic laryngitis. J Laryngol Otol. 1960;74:349–357
  45. Glanz H, Kleinsasser O. Chronische laryngitis und carcinoma. Arch Otolaryngol. 1976;212:57–75
  46. Vaezi MF, Hicks DM, Abelson TI, et al. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1:333–344
  47. Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg. 2000;123:385–388[erratum in: Otolaryngol Head Neck Surg 2001;124:104]
  48. Gallup Organization National Survey . Heartburn across America. Princeton (NJ): Gallup Organization; 1988;
  49. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead County, Minnesota. Gastroenterology. 1997;112:1448–1456
  50. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharyngeal findings associated with gastro esophageal reflux in normal volunteers. J Voice. 2002;16:564–579
  51. DeMeester TR, Johnson LF, Joseph GJ, et al. Pattern of gastroesophageal reflux in health and disease. Ann Surg. 1976;184:459
  52. Richter JE, DeMeester TR, Wu WC, et al. Normal 24-hour esophageal pH values: influence of age and gender. Gastroenterology. 1990;98:A122
  53. Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with reflux laryngitis. Gastroenterology. 1991;100:305–310
  54. Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology. 1995;109:1575–1582
  55. Shaker R, Bardan E, Gu C, et al. Intrapharyngeal distribution of gastric acid refluxate. Laryngoscope. 2003;113:1182–1191
  56. Geterude A, Bove M, Ruth M. Hypopharyngeal acid exposure: an independent risk factor for laryngeal cancer?. Laryngoscope. 2003;113:2201–2205
  57. Chen MY, Ott DJ, Casolo BJ, et al. Correlation of laryngeal and pharyngeal carcinomas and 24-hour pH monitoring of the esophagus and pharynx. Otolaryngol Head Neck Surg. 1998;119:460–462[retraction in Chen MY, Ott DJ, Koufman JA. Otolaryngol Head Neck Surg 1999;121:168]
  58. Adams J, Heintz P, Gross N, et al. Acid/pepsin promotion of carcinogenesis in the hamster cheek pouch. Arch Otolaryngol Head Neck Surg. 2000;126:405–409
  59. Adhami T, Goldblum JR, Richter JE, et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol. 2004;99:2098–2106
  60. Hill AB. The environment and disease: association or causation?. Proc R Soc Med. 1965;58:295–301
  61. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. Baltimore: Williams and Wilkins; 1996;
  62. Qadeer MA, Colabianchi N, Vaezi MF. Is GERD a risk factor for laryngeal cancer?. Laryngoscope. 2005;115:486–489
  63. Sung MW, Roh JL, Park BJ, et al. Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope. 2003;113:1059–1063
  64. Richtsmeier WJ, Eisele DW. In vivo reversal with cimetidine in patients with cancer. Arch Otol. 1986;112:1074–1077
  65. Richtsmeier WJ, Styczynski P, Johns ME. Selective, histamine-mediated immunosuppression in laryngeal cancer. Ann Otol Rhinol Laryngol. 1987;96:569–572
  66. Richtsmeier WJ. Letter to Ward in Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope. 1988;98:1195–1199

PII: S0196-0709(05)00139-0

doi: 10.1016/j.amjoto.2005.07.010

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 2 , Pages 119-128 , March 2006

Article Tools

* Image Usage & Resolution